3 results
Approved WMOCompleted
This study will evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of emicizumab in patients of all ages with mild (FVIII level between > 5% and < 40%) or moderate hemophilia A (FVIII level between >= 1% and…
Approved WMOCompleted
The study will investigate the safety and efficacy of emicizumab in patients with hemophilia A with inhibitors against FVIII.
Approved WMOCompleted
The main objective of this study is to evaluate the safety, including stent migration rates, and efficacy of placement of the esophageal multisegmented fully covered SEMS with the OTW method in patients with non-operable malignant obstruction of the…